CausalSentinel

Protein Dossier — KLKB1 (Plasma kallikrein)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Crohn’s disease 0.971 0.102 1.74e-21 Wald ratio 1 trans NA
Inflammatory bowel disease 0.653 0.0845 1.03e-14 Wald ratio 1 trans NA
Non-cancer illness code self-reported: hypopituitarism 0.000383 0.000128 0.00285 Inverse variance weighted 2 trans NA
Non-cancer illness code self-reported: hypopituitarism 0.000383 0.000128 0.00285 Inverse variance weighted 2 trans NA
Ulcerative colitis 0.319 0.107 0.0029 Wald ratio 1 trans NA
Non-cancer illness code self-reported: pulmonary embolism (with or without) dvt 0.0017 0.000623 0.00638 Inverse variance weighted 2 trans NA
Non-cancer illness code self-reported: pulmonary embolism (with or without) dvt 0.0017 0.000623 0.00638 Inverse variance weighted 2 trans NA
Paget’s disease 0.435 0.164 0.00807 Inverse variance weighted 2 trans NA
Paget’s disease 0.435 0.164 0.00807 Inverse variance weighted 2 trans NA
Thalamus volume -37.9 17.3 0.0284 Inverse variance weighted 2 trans NA
Thalamus volume -37.9 17.3 0.0284 Inverse variance weighted 2 trans NA
Eczema 0.102 0.047 0.0297 Inverse variance weighted 2 trans NA
…and 180 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-4152_58_2 Prekallikrein Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

307 association rows across 258 traits (300 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Circulating BCL2L11 levels 4e-480 rs4253281 3 GCST90860511 no MR -> candidate analysis
Circulating BMP6 levels 6e-447 rs4253252 1 GCST90859741 no MR -> candidate analysis
Plasma kallikrein levels 2e-426 rs71640035 6 GCST90249010 no MR -> candidate analysis
Kininostatin levels 3e-404 rs3733402 1 GCST90248200 no MR -> candidate analysis
KLKB1 protein levels 3e-291 rs4253327 5 GCST90469708 no MR -> candidate analysis
Circulating VEGFD levels (id: OID00468_OID20662) 2e-244 rs12331618 1 GCST90859829 no MR -> candidate analysis
CD84/ITGA6 protein level ratio 3e-237 rs4253252 1 GCST90313915 no MR -> candidate analysis
APOL1 protein levels 8e-229 rs4253281 1 GCST90468341 no MR -> candidate analysis
NPY protein levels 6e-201 rs4861708 1 GCST90470081 no MR -> candidate analysis
Serum levels of protein KLKB1 1e-191 rs2304595 1 GCST90088608 no MR -> candidate analysis
LGMN/SPINT2 protein level ratio 3e-172 rs4253252 1 GCST90315324 no MR -> candidate analysis
Circulating ITGA6 levels 1e-165 rs4253238 1 GCST90860190 no MR -> candidate analysis
…and 246 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 550 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
inherited prekallikrein deficiency 0.892 established (curated) no MR -> candidate analysis
prekallikrein deficiency 0.825 established (curated) no MR -> candidate analysis
Congenital prekallikrein deficiency 0.608 established (curated) no MR -> candidate analysis
venous thromboembolism 0.823 common-variant locus no MR -> candidate analysis
blood coagulation disease 0.655 established (curated) no MR -> candidate analysis
serum lipopolysaccharide activity 0.684 common-variant locus no MR -> candidate analysis
heart disorder 0.614 common-variant locus no MR -> candidate analysis
cardiovascular disorder 0.588 common-variant locus no MR -> candidate analysis
coronary artery calcification 0.579 common-variant locus no MR -> candidate analysis
pulmonary embolism 0.503 common-variant locus MR: beta=0.0017, p=0.00638 (trans)
drug allergy 0.416 common-variant locus no MR -> candidate analysis
Pulmonary Infarction 0.343 common-variant locus no MR -> candidate analysis
deep vein thrombosis 0.325 common-variant locus no MR -> candidate analysis
Thromboembolism 0.317 common-variant locus no MR -> candidate analysis
Thrombocytopenia 0.182 established (curated) no MR -> candidate analysis

Of the 15 rows above, 14 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 6 known modulators (Plasma kallikrein)
gnomAD constraint pLI=5.6e-16, LOEUF=0.98 — LoF-tolerant
GWAS Catalog 127 unique SNPs / 326 rows
ClinVar 383 records; 7 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance